Stanosafe
Stanosafe Uses, Dosage, Side Effects, Food Interaction and all others data.
Stanosafe is a synthetic anabolic steroid with therapeutic uses in treating hereditary angioedema. Stanosafe is derived from testosterone, and has been abused by several high profile professional athletes.
Stanosafe is a synthetic anabolic-androgenic steroid (AAS), which promotes cell growth (anabolism) and development/maintenance of masculine characteristics (androgenism).
| Trade Name | Stanosafe |
| Availability | Discontinued |
| Generic | Stanozolol |
| Stanozolol Other Names | Androstanazol, Androstanazole, Estanozolol, Stanozolol |
| Related Drugs | Orladeyo, danazol, Firazyr, Haegarda, Ruconest, Berinert, Danocrine, Cinryze, Kalbitor |
| Weight | 2mg |
| Type | Tablet |
| Formula | C21H32N2O |
| Weight | Average: 328.4916 Monoisotopic: 328.251463656 |
| Groups | Approved, Vet approved |
| Therapeutic Class | |
| Manufacturer | Konverge Healthcare Private Limited |
| Available Country | India |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Stanosafe is an anabolic steroid used to manage hereditary angioedema.
Stanosafe is a synthetic anabolic steroid with therapeutic uses in treating C1-inhibitor deficient hereditary angioedema. C1-inhibitor is a protease that inhibits the complement system (part of the innate immune system), a biochemical chain of reactions which assists the body in removing pathogens from the body. Stanosafe may help control attacks of hereditary angioedema. Stanosafe can be administered orally or intramuscularly.
Stanosafe is also used to associated treatment for these conditions: Hereditary Angioedema
How Stanosafe works
Stanosafe binds to androgen receptors, such as membrane bound receptor proteins LAGS and stanozolol-binding protein (STBP).
Stanosafe Cholesterol interaction
[Major] Androgenic anabolic steroids may adversely affect serum lipids, including lowering HDL and elevating LDL levels.
These changes can be marked, particularly with the 17-alpha-alkyl derivatives (i.e., fluoxymesterone, methyltestosterone, oxandrolone, oxymetholone, and stanozolol), and may significantly impact the risk of atherosclerosis and coronary artery disease.
Patients with preexisting hyperlipoproteinemia may require closer monitoring during therapy with androgenic agents, and adjustments made accordingly in their lipid-lowering regimen.
Androgen therapy should be administered cautiously in patients with coronary artery disease or a history of ischemic heart disease.
Stanosafe Drug Interaction
Unknown: amphetamine / dextroamphetamine, contained in alcoholic beverages , zolpidem, tadalafil, clomiphene, pancrelipase, cholecalciferol, testosterone, omega-3 polyunsaturated fatty acids, chorionic gonadotropin , ferrous sulfate, escitalopram, metoprolol, brexpiprazole, abacavir / dolutegravir / lamivudine, emtricitabine / tenofovir, diazepam, valacyclovir, sildenafil, cyanocobalamin
Half Life
24 hours
Innovators Monograph
You find simplified version here Stanosafe
